Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.
The interaction between laminin and the oncoprotein encoded by the c-erbB-2 oncogene was studied in vitro and in vivo in human breast carcinomas. In vitro analysis of breast carcinoma cell lines overexpressing p185HER2 revealed that laminin, but not fibronectin, induced tyrosine phosphorylation and...
Main Authors: | Tagliabue, E., Ardini, E., Pellegrini, R., Campiglio, M., Bufalino, R., Jeschke, M., Groner, B., Colnaghi, M. I., Ménard, S. |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
1996
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074760/ |
Similar Items
-
Identification of HER2-positive breast carcinomas as a particular subset with peculiar clinical behaviours
by: Casalini, P, et al.
Published: (2001) -
“Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas
by: Tagliabue, Elda, et al.
Published: (2014) -
Rescue of HER-2-positive breast carcinoma cells from dormancy by growth factors produced during wound healing
by: Agresti, R, et al.
Published: (2001) -
Prognosis based on primary breast carcinoma instead of pathological nodal status.
by: Ménard, S., et al.
Published: (1994) -
Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections.
by: Pfeiffer, P., et al.
Published: (1996)